Aytu BioPharma Inc. (AYTU) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Aytu BioPharma Inc.

NASDAQ: AYTU · Real-Time Price · USD
2.28
-0.05 (-2.15%)
At close: Sep 10, 2025, 1:06 PM

Aytu BioPharma Revenue

Aytu BioPharma reported an annual revenue of $81M, reflecting a -24.58% growth. For the quarter ending March 31, 2025, Aytu BioPharma generated $18.45M in revenue.
Revenue (ttm)
81M
Revenue Growth
-24.58%
Price / Sales Ratio
0.19
Revenue / Employee
794.14K
Employees
102
Market Cap
14.09M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Jun 30, 2024 81M -24.58%
Jun 30, 2023 107.4M +11.10%
Jun 30, 2022 96.67M +47.29%
Jun 30, 2021 65.63M +137.52%
Jun 30, 2020 27.63M +277.47%
Jun 30, 2019 7.32M +100.01%
Jun 30, 2018 3.66M +13.61%
Jun 30, 2017 3.22M +25.72%
Jun 30, 2016 2.56M +878.85%
Jun 30, 2015 261.78K +344.23%
Aug 31, 2014 58.93K +3267.37%
Aug 31, 2013 1.75K n/a
Aug 31, 2012 1.75K +Infinity%
Aug 31, 2011 0 n/a
Aug 31, 2010 0 -100.00%
Aug 31, 2009 1.75K +Infinity%
Aug 31, 2008 0 n/a
Aug 31, 2007 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.